Literature DB >> 16012124

Accuracy of noninvasive ejection fraction measurement in a large community-based clinic.

Dana E Habash-Bseiso1, Roxann Rokey, Charles J Berger, Andrew W Weier, Po-Huang Chyou.   

Abstract

OBJECTIVE: Compare the agreement of two dimensional echocardiography (echocardiography) and electrocardiogram (ECG)-gated single photon emission computed tomography (SPECT), with left ventricular contrast angiography (angiography) for the evaluation of left ventricular ejection fraction (LVEF).
DESIGN: Retrospective cohort study. DATA SOURCE: American College of Cardiology National Cardiovascular Data Registry(TM) (ACC-NCDR). PARTICIPANTS: Patients from a large, community-based clinic in central Wisconsin.
METHODS: Consecutive patients (1999-2002) were identified from the ACC-NCDR dataset who underwent angiography and echocardiography or SPECT within 1 month of each other for evaluation of LVEF. Noninvasive LVEF values were compared to those obtained by angiography using the paired t-test. Regression analysis was used to assess the relation between the compared methods. Bland-Altman analyses were performed to assess the agreement between LVEF values obtained by the noninvasive techniques and angiography. Sensitivity and specificity of detecting depressed LVEF were determined for noninvasive techniques. Regression equations were determined for estimating angiographic values from the echocardiographic or SPECT values.
RESULTS: Five hundred thirty-four patients underwent 542 angiographic studies: SPECT in all 534 patients, combined SPECT and echocardiographic studies in 201 patients, and combined angiographic and echocardiographic studies in 202 patients. Correlation of angiographic LVEFs with both echocardiographic and SPECT LVEFs was significant (r = 0.70 and r = 0.69, respectively; p < 0.0001). Echocardiographic LVEFs were lower than those determined by angiography (49% +/- 1.0% versus 54% +/- 1.0%; p < 0.0001). SPECT LVEFs were also lower than angiographic LVEFs (49% +/- 0.6% versus 57% +/- 0.6%; p < 0.0001). For 201 patients who underwent both SPECT and echocardiography, SPECT LVEFs were lower (47% +/- 1.0% for SPECT versus 49% +/- 1.0% for echocardiography; p < 0.05). Bland-Altman analysis revealed widely varying differences between techniques with broad confidence intervals. Nonetheless, sensitivity and specificity for determining LVEFs of <40% for SPECT and echocardiography were 90% and 86%, and 75% and 89%, respectively. LVEF of < or = 35% was correctly assessed by both SPECT and echocardiography. Sensitivity and specificity for SPECT were 82% and 89%, and 81% and 88% for echocardiography.
CONCLUSION: At our institution, LVEFs obtained noninvasively by echocardiography or SPECT are lower than angiographic LVEFs with widely fluctuating differences. Regression equations can be used to correct the noninvasive readings. Although lower, noninvasive techniques appear to accurately assess depressed LVEFs (<40% and <35%). The accuracy of noninvasive techniques for the evaluation of LVEF should be considered when managing and determining prognoses of patients with cardiac conditions. Individual institutions should determine the validity of the noninvasive techniques they use to assess LVEF.

Entities:  

Mesh:

Year:  2005        PMID: 16012124      PMCID: PMC1183436          DOI: 10.3121/cmr.3.2.75

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  23 in total

1.  Left ventricular volumes and ejection fraction calculated from quantitative electrocardiographic-gated 99mTc-tetrofosmin myocardial SPECT.

Authors:  J Yoshioka; S Hasegawa; H Yamaguchi; N Tokita; A K Paul; M Xiuli; A Maruyama; M Hori; T Nishimura
Journal:  J Nucl Med       Date:  1999-10       Impact factor: 10.057

2.  Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography.

Authors:  Rainer Hoffmann; Stephan von Bardeleben; Folkert ten Cate; Adrian C Borges; Jaroslaw Kasprzak; Christian Firschke; Stephane Lafitte; Nidal Al-Saadi; Stefanie Kuntz-Hehner; Marc Engelhardt; Harald Becher; Jean Louis Vanoverschelde
Journal:  Eur Heart J       Date:  2004-12-17       Impact factor: 29.983

3.  Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil. Symptom, Tolerability, Response to Exercise Trial of Candesartan Cilexetil in Heart Failure (STRETCH) Investigators.

Authors:  G A Riegger; H Bouzo; P Petr; J Münz; R Spacek; H Pethig; V von Behren; M George; H Arens
Journal:  Circulation       Date:  1999-11-30       Impact factor: 29.690

Review 4.  New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.

Authors:  H Klein; A Auricchio; S Reek; C Geller
Journal:  Am J Cardiol       Date:  1999-03-11       Impact factor: 2.778

5.  Left ventricular volumes, ejection fraction, and regional wall motion calculated with gated technetium-99m tetrofosmin SPECT in reperfused acute myocardial infarction at super-acute phase: comparison with left ventriculography.

Authors:  M Abe; Y Kazatani; H Fukuda; H Tatsuno; H Habara; H Shinbata
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

6.  [Determination of ejection fraction and left ventricular fraction using isotopic ventriculography and bidimensional echocardiography. Comparison with contrast ventriculography].

Authors:  I Casáns Tormo; R Gómez Aldaravi; V Bodí Peris; J Sanchis Forés; J Ciudad Platero; L Insa Pérez; J Manjón Soriano
Journal:  Rev Esp Cardiol       Date:  1998       Impact factor: 4.753

7.  Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

Authors:  R S McKelvie; S Yusuf; D Pericak; A Avezum; R J Burns; J Probstfield; R T Tsuyuki; M White; J Rouleau; R Latini; A Maggioni; J Young; J Pogue
Journal:  Circulation       Date:  1999-09-07       Impact factor: 29.690

8.  Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

Authors:  B Pitt; R Segal; F A Martinez; G Meurers; A J Cowley; I Thomas; P C Deedwania; D E Ney; D B Snavely; P I Chang
Journal:  Lancet       Date:  1997-03-15       Impact factor: 79.321

9.  Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: design and first results of the Marburg Cardiomyopathy Study.

Authors:  W Grimm; C Glaveris; J Hoffmann; V Menz; N Mey; S Born; B Maisch
Journal:  Pacing Clin Electrophysiol       Date:  1998-11       Impact factor: 1.976

10.  Relationship of gated SPECT ventricular function parameters to angiographic measurements.

Authors:  K Nichols; J Tamis; E G DePuey; J Mieres; S Malhotra; A Rozanski
Journal:  J Nucl Cardiol       Date:  1998 May-Jun       Impact factor: 5.952

View more
  17 in total

1.  Ejection fraction derived by noninvasive modalities versus left ventricular angiographic determination.

Authors:  Tahir Tak
Journal:  Clin Med Res       Date:  2005-05

2.  Gated SPECT: what's the ideal method to measure LVEF?

Authors:  Sum-Che Man; Ernst E van der Wall; Cees A Swenne
Journal:  Int J Cardiovasc Imaging       Date:  2008-09-02       Impact factor: 2.357

Review 3.  Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Authors:  Saro H Armenian; Melissa M Hudson; Renee L Mulder; Ming Hui Chen; Louis S Constine; Mary Dwyer; Paul C Nathan; Wim J E Tissing; Sadhna Shankar; Elske Sieswerda; Rod Skinner; Julia Steinberger; Elvira C van Dalen; Helena van der Pal; W Hamish Wallace; Gill Levitt; Leontien C M Kremer
Journal:  Lancet Oncol       Date:  2015-03       Impact factor: 41.316

4.  Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure.

Authors:  F Lennie Wong; Smita Bhatia; Wendy Landier; Liton Francisco; Wendy Leisenring; Melissa M Hudson; Gregory T Armstrong; Ann Mertens; Marilyn Stovall; Leslie L Robison; Gary H Lyman; Steven E Lipshultz; Saro H Armenian
Journal:  Ann Intern Med       Date:  2014-05-20       Impact factor: 25.391

5.  Specialized survivor clinic attendance increases adherence to cardiomyopathy screening guidelines in adult survivors of childhood cancer.

Authors:  Kristin C Marr; Mohammad Agha; Rinku Sutradhar; Jason D Pole; David Hodgson; Astrid Guttmann; Mark Greenberg; Paul C Nathan
Journal:  J Cancer Surviv       Date:  2017-08-07       Impact factor: 4.442

6.  Contractility evaluation by 2 dimensional echocardiography and gated SPECT myocardial perfusion scintigraphy in hypertensive patients with clinical presentation of atypical chest pain.

Authors:  H Yalçin; B Karayalçin; A Boz; B Talay; A Belgi; F Yalçin
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

7.  Are ejection fraction measurements by echocardiography and left ventriculography equivalent?

Authors:  Samuel W Joffe; Jarrod Ferrara; Armen Chalian; Dennis A Tighe; Gerard P Aurigemma; Robert J Goldberg
Journal:  Am Heart J       Date:  2009-08-04       Impact factor: 4.749

8.  Assessment of an intermediate reprojection technique transitioning from planar to SPECT radionuclide ventriculography.

Authors:  Jim O'Doherty; Bruno Rojas Fisher; Jonathan Mark Price; Kshama Wechalekar
Journal:  J Nucl Cardiol       Date:  2014-08-01       Impact factor: 5.952

9.  Comparison and co-relation of invasive and noninvasive methods of ejection fraction measurement.

Authors:  Darshan Godkar; Kalyan Bachu; Bijal Dave; Robert Megna; Selva Niranjan; Ashok Khanna
Journal:  J Natl Med Assoc       Date:  2007-11       Impact factor: 1.798

10.  Left ventricular ejection fraction measurements: accuracy and prognostic implications in a large population of patients with known or suspected ischemic heart disease.

Authors:  Alessia Gimelli; Patrizia Landi; Paolo Marraccini; Rosa Sicari; Paolo Frumento; Antonio L'Abbate; Daniele Rovai
Journal:  Int J Cardiovasc Imaging       Date:  2008-07-09       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.